Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101659971A reveals a lipase-catalyzed route for stable hemiaminal synthesis, offering cost reduction in pharmaceutical intermediate manufacturing and reliable supply chain solutions.
Novel solid acid catalysis method for Vitamin K1 ensures high purity and green manufacturing. Ideal for reliable vitamin K1 supplier partnerships seeking cost reduction.
Patent CN105879905B details a novel chiral phosphine catalyst enabling asymmetric RC reactions with high enantioselectivity, offering cost and supply advantages.
Patent CN102212570B details a biocatalytic route for L-ascorbyl conjugated linoleate, offering high purity and cost-effective production for nutritional applications.
Patent CN1842533A discloses novel P,N-ligands enabling high-ee hydrogenation. Offers supply chain stability for chiral pharmaceutical intermediate manufacturing.
Patent CN112898156A reveals a novel molecular sieve catalyzed recovery process for 1-(3,3-dimethylcyclohexyl) ethanol, enhancing yield and reducing waste in Musk Eden manufacturing.
Novel patent CN106008596B enables efficient synthesis of 4-(hydroxymethylphosphoryl)-2-carbonylbutanoic acid with improved yield and scalability for global supply chains.
Patent CN101260415A reveals high-efficiency biocatalytic route for chiral intermediates. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel SnCl2/oxidant system enables high-yield Povarov reaction with aliphatic aldehydes, offering cost-effective pharma intermediate manufacturing.
Patent CN104130187B details efficient asymmetric synthesis. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing supply chain.
Patent CN113336792A reveals a novel Lewis acid-catalyzed synthesis for cyclic phosphonates, offering superior stereoselectivity and yield for pharmaceutical manufacturing.
Patent CN106434611A details a high-yield enzymatic route for L-Ornithine, offering superior purity and supply chain stability for nutritional and pharmaceutical applications.
Discover a cost-effective, non-cyanide route for high-purity polymethoxy phenylacetic acid. Ideal for API synthesis like CA4 and Pterostilbene precursors.
Patent CN110981676A discloses a metal-free visible light method for beta-ketosulfones. Offers cost reduction and green manufacturing for pharmaceutical intermediates.
Patent CN1205196C reveals a novel C(10) selective acylation method for 10-DAB. Discover cost-effective taxane intermediate manufacturing and supply chain advantages.
Novel metal-free decarboxylative ketonization method offers cost-effective, scalable production of high-purity pharmaceutical intermediates with green chemistry advantages.
Patent CN107759619B reveals a mild organocatalytic route for dihydropyrano-thiazoles, offering high yields and stereocontrol for reliable pharmaceutical intermediate supply chains.
Patent CN102146097A reveals a solvent-free DOPO synthesis route. Achieve >99% purity with reduced equipment costs for polymer additive manufacturing.
Novel isopropanol-based method for N-hydroxyphthalimide production. Reduces toxicity, simplifies purification, ensures high purity for reliable pharmaceutical intermediates supply chains.
Patent CN107056796B details a novel copper-catalyzed synthesis route offering high stereoselectivity and simplified processing for scalable pharmaceutical intermediate manufacturing supply chains.